Objective: To determine the ability of clinical measures of balance to distinguish fallers from non-fallers and to determine their predictive validity in identifying those at risk of falls. Data sources: AMED, CINAHL, Medline, Scopus, PubMed Central and Google Scholar. First search: July 2015. Final search: October 2017. Review methods: Inclusion criteria were studies of adults with a definite multiple sclerosis diagnosis, a clinical balance assessment and method of falls recording. Data were extracted independently by two reviewers. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 scale and the modified Newcastle-Ottawa Quality Assessment Scale. Statistical analysis was conducted for the cross-sectional studies using Review Manager 5. The mean difference with 95% confidence interval in balance outcomes between fallers and non-fallers was used as the mode of analysis. Results: We included 33 studies (19 cross-sectional, 5 randomised controlled trials, 9 prospective) with a total of 3901 participants, of which 1917 (49%) were classified as fallers. The balance measures most commonly reported were the Berg Balance Scale, Timed Up and Go and Falls Efficacy Scale International. Meta-analysis demonstrated fallers perform significantly worse than non-fallers on all measures analysed except the Timed Up and Go Cognitive (p < 0.05), but discriminative ability of the measures is commonly not reported. Of those reported, the Activities-specific Balance Confidence Scale had the highest area under the receiver operating characteristic curve value (0.92), but without reporting corresponding measures of clinical utility. Conclusion: Clinical measures of balance differ significantly between fallers and non-fallers but have poor predictive ability for falls risk in people with multiple sclerosis.
Introduction
Previous studies have found falls prevalence to be as high as 56% among people with multiple sclerosis, with 37% of those falling classed as frequent fallers. 1 Injurious falls can be serious in this group 2 and both the high rate of falls and high levels of concern about falling may lead to activity curtailment and further reductions in physical fitness and endurance. 3 Several factors have been shown to be associated with an increased risk of falls in multiple sclerosis 4 including longer disease duration, more progressive disease course, use of a mobility device, slower gait speed and impaired balance. Having a balance impairment has a pooled odds ratio of 1.07 (95% confidence interval (CI) 1.04-1.10) for falls among people with multiple sclerosis. 5 While these earlier reviews 4, 5 have identified that impaired balance is associated with increased falls risk, no systematic review to date has examined the predictive validity of the various clinical measures of balance used to identify falls risk.
A wide range of clinical tests and self-report measures have been used to evaluate balance and falls risk in multiple sclerosis [6] [7] [8] [9] using different observational methods. The International Multiple Sclerosis Falls Prevention Research Network recommended the assessment of dynamic balance 10 in falls prevention research, but it acknowledged that there is not enough evidence to specifically recommend one measure over any other. Thus, the objective of this systematic review and meta-analysis is to investigate the relationship between clinical balance measures and falls in people with multiple sclerosis. First, we will examine if clinical balance measures demonstrate different scores in fallers and non-fallers in cross-sectional studies of people with multiple sclerosis and second, we will determine the discriminative ability and clinical utility for assessing falls in prospective cohort studies. We hypothesise that there will be a significant difference between scores in fallers and non-fallers on these clinical balance measures, and that measures with an area under the receiver operating characteristic curve statistic value of 0.7 or greater and a sensitivity of at least 80% will be suitable to use in identifying falls risk.
Methods
This study consists of a systematic review and meta-analysis. The Meta-analysis of Observational Studies in Epidemiology 11 standardised reporting guidelines were followed to ensure the standardised conduct and reporting of the research. A systematic literature search was conducted by the primary author (G.Q., PhD candidate), with the first search carried out in July 2015 and the final search carried out in October 2017, and included the following databases: AMED, CINAHL, Medline (through EBSCO search platform), Scopus and PubMed Central. Keywords were formed by examining the search strategy in other systematic reviews in this area and by checking citations and keywords from results of a preliminary search in Google Scholar. The keywords and MeSH headings utilised as search terms were 'multiple sclerosis' OR 'MS' AND 'balance' OR 'postural control' OR 'postural instability' OR 'imbalance' OR 'stability' AND 'fall*' OR 'fall risk'. The search was supplemented through the searching of references lists of returned articles and the use of the same search terms in Google Scholar. No restrictions were placed on language or year of publication. See online Appendix 1 for more details of search strategy.
Inclusion criteria were studies of adults with a definite multiple sclerosis diagnosis, use of a clinical balance measure and a method of falls reporting. Cross-sectional studies were included where fallers were compared to non-fallers and prospective cohort studies were also included where balance measures were administered prior to a subsequent falls event. Baseline data from randomised controlled trials were suitable for inclusion in the meta-analysis if authors provided the relevant data when contacted and if falls were an outcome of interest in the study. Studies were excluded from this review if laboratory-based measures only were used (e.g. limits of stability using the Smart Balance Master or static posturography using force platforms) or if the cohort consisted of a mixed neurological population.
Two reviewers (G.Q. and S.C.) read the titles and/or abstracts of the identified studies and discarded irrelevant studies. Studies considered to be eligible for inclusion were read in full and their suitability for inclusion was determined independently by two reviewers (G.Q., S.C.). Where disagreement occurred, discussions took place until consensus was reached. The authors were contacted to provide supplementary information when insufficient data were provided in the publication. If two studies were found to involve the same patient cohort, only one study was included in the meta-analysis. Information relating to authors and year of publication, study design and setting, eligibility criteria, population demographics and outcomes of balance measures were extracted to provide summary tables.
The quality of included prospective cohort studies was assessed using the validated Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) Scale. 12 The tool considers risk of bias and applicability concerns and consists of four main domains -patient selection, index test, reference standard and flow of patients through the study including timing of the index test and reference standard. Risk of bias is judged as 'low', 'high' or 'unclear'. The quality of the cross-sectional studies was assessed using the NewcastleOttawa Quality Assessment Scale adapted for cross-sectional studies. 13 It involves three sub-sections: the selection of cases, the comparability of different outcome groups and the outcome itself. A star system is used to allow a semi-quantitative assessment of study quality and a maximum score of 10 stars may be awarded depending on the criteria level the study meets in each section. Two of the authors (G.Q. and L.C.) independently assessed the methodological quality of the studies. Where disagreement occurred, deliberation took place until consensus was reached.
Meta-analysis of the prospective cohort studies was not possible due to the heterogeneous nature of the outcomes administered and the variability in follow-up time-points. However, the findings of these studies are summarised relating to the discriminative ability and clinical utility of the balance measures. Discrimination, the ability of a measure to differentiate between individuals with and without falls, was quantified using the area under the receiver operating characteristic curve statistic. A value of 0.5 represents chance, values between 0.7 and 0.9 represent moderate discrimination and a value of 1 represents perfect discrimination. 14 The clinical utility of the outcome measures was assessed using the summary estimates of sensitivity and specificity.
Statistical analysis was conducted for the cross-sectional studies with retrospectively collected falls data using Review Manager 5 (Version 5.3). The mean difference (MD) with 95% CI in balance outcomes between fallers and non-fallers was used as the mode of analysis. We addressed the impact of sample size by estimating a weighting factor for each study and assigning larger effect-weights in studies with larger samples. Heterogeneity was examined using the I 2 statistic. We used the Cochrane interpretation of these values where an I 2 value of 30%-60% indicates moderate heterogeneity and an I 2 value of 50%-90% demonstrates substantial heterogeneity. 15 When the pooled data indicated moderate or substantial heterogeneity, we completed our meta-analysis using the more conservative random-effects modelling approach instead of the fixed-effects model (FEM). Where reported outcomes had a scale where a lower value is indicative of a worse outcome, the reported values were multiplied by −1 so that in all analyses a lower value indicated a better outcome. 16 Figure 1 shows the flow of studies through the review selection process. Of the 33 studies eligible for inclusion, 9 were prospective cohort studies, [17] [18] [19] [20] [21] [22] [23] [24] [25] 19 were cross-sectional studies 6, 8, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] and 5 were randomised controlled trials with appropriate cross-sectional data. [43] [44] [45] [46] [47] In total, 12 authors were contacted for additional data, 10 of whom returned data in relation to 12 different studies. Both fall definition and numbers of falls needed to be classified as a faller varied widely across the included studies with seven different fall definitions reported and two faller classifications, see online Appendices 2 and 3.
Results

Study selection
A detailed summary of included studies is provided in online Appendix 2 (prospective studies) and online Appendix 3 (cross-sectional studies). Within the prospective studies, the participant numbers in the multiple sclerosis group ranged across studies from 38 participants 20 to 416 participants 24 with a total of 1223 multiple sclerosis participants across the nine prospective studies. The range of mean ages reported by the prospective studies for people with multiple sclerosis was 30.29 years 18 to 57 years 21 and six of the nine studies reported mean disease duration with averages ranging from 4.02 years 18 to 14.37 years. 20 The mean Expanded Disability Status Scale scores ranged from 2.8 17 to 5. 23 The duration of falls recording using falls diaries or calendars varied from 3 months 21,23,24 to 12 months. 20, 22 The incidence of falls across these studies ranged from 41% 24 to 71% 17 with a mean incidence of 56% across the nine studies.
The participant numbers in the cross-sectional studies and randomised controlled trials varied from 12 33 to 402 38 with a total number of 2678 across the 24 studies. The mean ages reported ranged from 40 years 31 to 59 years 46 and mean disease duration was reported in 20 of these studies with averages ranging from 4.3 years 31 to 20.85 years. 47 Expanded Disability Status Scale score was reported by 16 studies and the mean score ranged from 1.7 31,39 to 6.11. 47 Fallers were identified using a falls history ranging from 1 month recall 6 to 12 month recall. 8, 26, 32, 36, [38] [39] [40] [41] [42] The prevalence of falls across these studies ranged from 23% 27 to 76%, 36 with an overall prevalence of 46%. 
Balance measures
Quality assessment
A detailed overview of the methodological quality of the 33 studies is provided in supplementary  Table 1a (cohort studies) and supplementary Table  1b (cross-sectional studies and randomised controlled trials). In the two QUADAS-2 domains of patient selection and reference standard, all nine prospective studies showed low risk of bias in relation to applicability, indicating an appropriate cohort was studied with a suitable method of falls recording. No study demonstrated a low risk of bias in all domains with only one study 23 achieving a low risk of bias in six of the seven domains. The total scores on the modified Newcastle-Ottawa Scale ranged from 3 stars 26 to 8 stars 28,44 across the cross-sectional studies. One of the studies was classified as high risk of bias (1-3 stars) 26 and nine of the studies (14%) were medium risk (4-5 stars) with the remaining fourteen studies (81%) classed as low risk of bias (6-9 stars).
In relation to the discriminative ability of the clinical measures, Table 1 presents the results of the studies. Only two studies reported the area under the receiving operating characteristic curve statistic, the sensitivity, specificity and cut-off value. 19, 25 Of the 10 clinical balance measures investigated in the cohort studies, the Berg Balance Scale was one of the most commonly reported measures and was the only measure with both an area under the receiver operating characteristic curve statistic value of greater than 0.7 20 and a sensitivity of greater than 80%. 23 However, another study reported a conflicting sensitivity score for the Berg Balance Scale of 32%. 24 The other two measures with reported area under the receiver operating characteristic curve statistic values of greater than 0.7 were the Activities-specific Balance Confidence Scale and The Falls Efficacy Scale International 18 but with no corresponding sensitivity or specificity values.
Meta-analysis of cross-sectional studies
Results of the meta-analysis for clinical measures are displayed in Figure 2 . Ten studies used the Berg Balance Scale 48 to compare balance across fallers and non-fallers. 6, 27, 33, 35, 41, [43] [44] [45] [46] [47] Fallers demonstrated significantly lower balance scores than their counterparts without a history of falls, as presented in Figure 2 (a) (FEM, MD = 2.72, 95% CI (1.53-3.92), P < 0.01, I 2 = 30%). Three of the studies 27, 41, 47 included in the meta-analysis for this measure had an overall medium risk of bias based on methodological quality score, and the other eight were deemed low risk of bias (Newcastle-Ottawa Scale score of 6 to 8).
The Dynamic Gait Index 49 was used in five studies. 6, 27, 29, 34, 43 The findings from these pooled studies (Figure 2(b) ) demonstrate that fallers report significantly lower scores than non-fallers and two 27, 34 of the five studies included had a medium risk of bias. Five of the nine studies included in meta-analysis for the Timed Up and Go 50 had a medium risk of bias, with the remaining studies demonstrating a low risk of bias, and the pooled meta-analysis did demonstrate a significant difference between fallers and non-fallers on this measure (Figure 2(c)) .
Results for the Timed Up and Go Cognitive, 51 Mini-BESTest 52 and Four Square Step Test 53 are seen in Figure 2 Step Test should be interpreted with caution as they had only small numbers of studies suitable for inclusion (two to four for each analysis).
Findings from the meta-analysis for selfreport measures, the Activities-specific Balance Confidence Scale 54 and the Falls Efficacy Scale International 55 are seen in Figure 3(a) and (b) . A significant difference across fallers and nonfallers was noted for both these measures. The meta-analysis for both these measures included one study with an overall medium risk of bias and this must be remembered when interpreting the results. Step Test scores between fallers and non-fallers.
Discussion
In this review exploring the differences in balance between fallers and non-fallers with multiple sclerosis and the discriminative ability and clinical utility of clinical balance measures for falls prediction, we found a total of 33 studies suitable for inclusion. The most commonly reported clinical measures were the Berg Balance Scale, the Timed Up and Go, Activities-specific Balance Confidence Scale and Falls Efficacy Scale International. These measures do demonstrate a significant difference between fallers and non-fallers but have conflicting sensitivity values reported and often no area under the receiver operating characteristic curve statistic value reported or poor discriminative ability demonstrated. There is currently insufficient evidence from the nine prospective studies to support any balance measure as a falls prediction tool for people with multiple sclerosis. From the limited number of prospective studies, there were only three reported measures demonstrating an area under the receiver operating characteristic curve statistic value of moderate discrimination: the Activities-specific Balance Confidence Scale, 18 the Falls Efficacy Scale International 18 and the Berg Balance Scale. 20 No study reported corresponding sensitivity and specificity values together with the area under the receiver operating characteristic curve statistic value for these measures, but two different studies did report conflicting sensitivity values for the Berg Balance Scale with one study reporting a high sensitivity value (greater than 80%) 23 and another study reporting a contrasting sensitivity value of 32%. 24 This conflicting value may be due to the variance in study population in the two cohorts with the latter study's participants representing a milder disease stage and a younger age profile than the former study. 23 The Berg Balance Scale should not be used to identify falls risk in multiple sclerosis until there is a stronger evidence base available demonstrating good discriminative ability and satisfactory clinical utility.
Our results are somewhat similar to a previous review by Giannì et al., 4 who found that measures such as the Berg Balance Scale and Timed Up and Go demonstrated poorer performance in fallers when compared to non-fallers. However, those authors meta-analysed data from both prospective and cross-sectional studies, thus diluting the validity of their pooled results. Gunn et al. 5 looked at risk factors associated with falls in multiple sclerosis and found that balance impairment was associated with falling (pooled OR of 1.07, 95% CI 1.04-1.10). Like our findings, they also reported low measures of sensitivity in the balance measures used and concluded that the use of a balance measure alone is not appropriate when falls screening for people with multiple sclerosis. Given that studies from other populations 56, 57 suggest that a balance measure alone may not have sufficient clinical utility to predict falls, we suggest those measures with significant differences on meta-analysis should be considered for evaluation in future studies in combination with other clinical variables.
There are a number of strengths associated with this systematic review. A robust methodological approach was employed to identify and select 33 unique studies relevant for inclusion which is higher than the previous reviews. 4, 5 We utilised rigorous methods to select and carefully appraise appropriate studies from a variety of databases. However, the findings need to be interpreted in the context of our study limitations. We originally proposed to investigate only prospective cohort studies; however, a scoping search indicated that there were a limited number of papers reporting this reference standard. We therefore included data from cross-sectional studies comparing balance scores in people who do and do not report falls in this systematic review and meta-analysed that data. There was a lack of standardised conduct and reporting across the included studies with significant heterogeneity in the range of outcomes used. A strength is that we included all available studies; however, a limitation is that some were of low methodological quality. The lack of a 'cut off' or definition of 'good' or 'excellent' for the tools used meant that a clear rationale for excluding studies was not available and we did not use a sensitivity analysis to exclude certain studies from the meta-analyses.
A further limitation of this review is that we did not specify the fall definition or faller classification as part of our inclusion criteria. Our results demonstrate a wide variety of fall definitions and faller classifications and this, and lack of consideration of clinical heterogeneity due to multiple sclerosis type or level of disability weakens the findings from our meta-analyses. Only nine studies in this review used the gold standard of prospective falls recording with diaries as recommended by falls prevention networks such as the Prevention of Falls Network Europe 58 and the International Multiple Sclerosis Falls Prevention Research Network. 59 We used a broad range of search terms to try and find all suitable studies, but the large numbers returned in our initial results may have resulted in suitable studies being missed at the screening stage. We chose to exclude laboratory-based measures of balance such as posturography using force plate platforms due to the lack of clinical applicability. However, there is a growing body of evidence on their discriminative ability and clinical utility in people with multiple sclerosis 60 and in the use of inertial sensors and instrumented gait tests to detect balance impairments in this population. 61, 62 In conclusion, it is not currently possible to recommend any clinical balance measure for assessing falls risk in multiple sclerosis. From the small number of prospective studies presented in this review, it is clear that we do not have enough information about the predictive validity of the current measures commonly used to recommend any specific one. Given the multifactorial nature of falls, balance measures alone may not have adequate falls prediction ability. Similar to research on falls risk in older people, 63 the use of quick screening questions rather than results of a lengthy assessment may more reliably identify those at risk, and further research should consider this direction.
Clinical messages
• • Meta-analysis shows fallers perform significantly worse than non-fallers on commonly used measures such as the Berg Balance Scale and Timed Up and Go, but the discriminative ability of these clinical measures is poor. • • It is not possible to recommend any clinical balance measure for assessing falls risk in multiple sclerosis.
